Left ventricular function and collagen content after regression of hypertensive hypertrophy

Area of Science:

• Cardiovascular Physiology
• Pharmacology
• Nephrology

Background:

• Hypertensive hypertrophy is a common complication of uncontrolled hypertension.
• Left ventricular remodeling, including collagen deposition, impairs cardiac function.
• The effects of blood pressure control on cardiac collagen and function require further investigation.

Purpose of the Study:

• To investigate the impact of antihypertensive treatment on left ventricular collagen and diastolic/systolic function.
• To determine if regression of hypertensive hypertrophy correlates with changes in myocardial stiffness and collagen content.
• To assess the efficacy of nifedipine in reversing cardiac structural and functional changes in spontaneously hypertensive rats.

Main Methods:

• Spontaneously hypertensive rats received nifedipine (30 mg/kg/day) for 20 weeks.
• Left ventricular collagen was quantified using hydroxyproline concentration.
• Myocardial stiffness was assessed via the tangent modulus Km.
• Cardiac function was evaluated by peak systolic pressure and cardiac output.

Main Results:

• Nifedipine treatment significantly reduced systolic aortic pressure (187 to 144 mm Hg).
• Left ventricular hypertrophy regressed, as indicated by a lower left ventricular muscle/body weight ratio.
• The study suggests that nifedipine treatment may normalize myocardial stiffness and collagen levels, though further data is needed.

Conclusions:

• Blood pressure control with nifedipine effectively reduces hypertensive cardiac hypertrophy.
• Regression of hypertrophy is associated with improvements in left ventricular collagen and function.
• Nifedipine offers a potential therapeutic strategy for mitigating hypertensive cardiac damage.